Baidu
map
EXPERT REV VACCINES 润色咨询

Expert Review of Vaccines

出版年份：2002 年文章数：1031 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：5.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2170772, encodeId=9fd121e07722f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：疫苗相关临床研究<br>经验分享：对新颖度要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7cb5018653, createdName=4126526, createdTime=Fri Nov 24 15:29:03 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1090485, encodeId=a80d109048550, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090486, encodeId=13bf109048684, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-11-24 4126526 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：疫苗相关临床研究
    经验分享：对新颖度要求较高

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2170772, encodeId=9fd121e07722f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：疫苗相关临床研究<br>经验分享：对新颖度要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7cb5018653, createdName=4126526, createdTime=Fri Nov 24 15:29:03 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1090485, encodeId=a80d109048550, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090486, encodeId=13bf109048684, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-28 rayms

    对于审稿人好的意见也要回复么？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2170772, encodeId=9fd121e07722f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：疫苗相关临床研究<br>经验分享：对新颖度要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7cb5018653, createdName=4126526, createdTime=Fri Nov 24 15:29:03 CST 2023, time=2023-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1090485, encodeId=a80d109048550, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090486, encodeId=13bf109048684, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    上传文章有什么要求？

    1

    展开1条回复
共5条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map